UK markets open in 5 hours 52 minutes
  • NIKKEI 225

    27,517.52
    -124.31 (-0.45%)
     
  • HANG SENG

    26,194.82
    -40.98 (-0.16%)
     
  • CRUDE OIL

    70.18
    -0.38 (-0.54%)
     
  • GOLD FUTURES

    1,813.30
    -0.80 (-0.04%)
     
  • DOW

    35,116.40
    +278.24 (+0.80%)
     
  • BTC-GBP

    27,613.87
    -684.60 (-2.42%)
     
  • CMC Crypto 200

    938.48
    -4.96 (-0.53%)
     
  • ^IXIC

    14,761.29
    +80.23 (+0.55%)
     
  • ^FTAS

    4,074.79
    +13.67 (+0.34%)
     

Global CRO Market Size & Growth Projections Report 2021-2025: Projected Spending on Development, Phase I-IV Development, and Outsourced Phase I-IV Development

·3-min read

Dublin, July 06, 2021 (GLOBE NEWSWIRE) -- The "2021 CRO Market Size & Growth Projections" report has been added to ResearchAndMarkets.com's offering.

Overall, 2020 was not a horrible year for CROs.

Yes, we predicted an overall downturn in the market and we are sticking by that based mainly on the hypothesis that the large CROs fared better than the smaller ones.

What do the financial numbers tell us?

They tell us proposals, RFPs, and contracting were strong in 2020, as witnessed by the impressive growth in backlog. The numbers also tell us that the larger CROs struggled a bit turning the backlog into revenue, which is highly understandable given how much of the healthcare system was under attack in 2020.

If first quarter 2021 numbers are any indication, it looks like the future is quite positive for the larger CROs as they work through record-level backlog levels.

The report provides quantitative analysis into the constant question, "What is the size of the CRO market?" The data within are segmented by phase, geography and service line in order to generate a full picture of the clinical development services market.

What You Will Learn:

  • Estimated R&D expenditures through 2025

  • Projected spending on development, Phase I-IV development, and outsourced Phase I-IV development through 2025, segmented by sponsor type:

    • Large pharma - large molecule

    • Large pharma - small molecule

    • Non-large pharma - large molecule

    • Non-large pharma - small molecule

    • Generic/Specialty

    • Government

    • Private

    • Association/Non-profit

    • Academic

  • Spending on CRO services segmented by:

    • Geography

    • Service-line

    • Phase I-IV

Major Topics:

  • Overall Market Size and Growth

  • 2021 Geographic Assessment

  • 2021 Service-line Assessment

  • 2021 Development Phase I-IV Assessment

  • 2020-2025 CRO Market Model

  • 2021 Public CRO Market Share

Key Topics Covered:

1. Overall Market Size and Growth

  • Top-Down Approach to Market Size

  • R&D Sources and Distribution

  • R&D Expenditures by Segment (2020-2025)

  • Model Adjustments - From R&D to CRO Market Size

  • Development Spending

  • Development as a Percent of R&D by Segment (2021)

  • Development Expenditures by Segment (2020-2025)

  • Phase I-IV Development Spending

  • Ph I-IV Development as a Percent of Development by Segment (2021)

  • Ph I-IV Development Expenditures by Segment (2020-2025)

  • Outsourced Phase I-IV Development Spending

  • Outsourced Ph I-IV Development as a Percent of Development by Segment (2020-2025)

  • Outsourced Ph I-IV Development Expenditures by Segment (2020-2025)

  • 2021 Full Model Analysis

2. 2021 Geographic Assessment

  • 2021 Geographic Distribution (%) of the CRO Market Size

  • 2021 Geographic Distribution ($B) of the CRO Market Size

3. 2021 Service-Line Assessment

  • 2021 Service-Line Distribution (%) of the CRO Market Size

  • 2021 Service-Line Distribution ($B) of the CRO Market Size

4. 2021 Development Phase I-IV Assessment

  • 2021 Development Phase Distribution (%) of the CRO Market Size

  • 2021 Development Phase Distribution ($B) of the CRO Market Size

5. 2020-2025 CRO Market Model

6. 2018 Public CRO Market Share

  • 2018 Public CRO Market Shares

For more information about this report visit https://www.researchandmarkets.com/r/gi8myo

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900


Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting